Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company has a strategic collaboration with Leica Biosystems and Daiichi Sankyo Company, Limited for the development of an immunohistochemistry assay and an image analysis algorithm for the TROP2 NMR biomarker in non-small cell lung cancer. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Key Metrics
as of Sep 2026
Market Cap 17,360 Cr
P/E 100.00
Div Yield 0.52 %
Book Value โน349.00
52w High โน9,850.00
52w Low โน6,832.00
Face Value โน2.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
683.00
579.00
612.00
559.00
526.00
480.00
440.00
408.00
388.00
383.00
306.00
311.00
295.00
Expenses
634.00
518.00
567.00
484.00
445.00
394.00
363.00
355.00
349.00
334.00
291.00
258.00
228.00
Operating Profit
49.00
61.00
45.00
75.00
81.00
86.00
77.00
53.00
38.00
49.00
15.00
53.00
67.00
OPM %
7.00
11.00
7.00
13.00
15.00
18.00
17.00
13.00
10.00
13.00
4.90
17.00
23.00
Other Income
9.00
5.00
7.00
1.00
11.00
10.00
-26.00
8.00
-49.00
9.00
10.00
25.00
8.00
Depreciation
5.00
6.00
4.00
3.00
17.00
18.00
9.00
9.00
4.00
4.00
4.00
4.00
4.00
Interest
2.00
2.00
1.00
1.00
1.00
1.00
0.00
0.00
0.00
0.00
1.00
0.00
0.00
Profit before tax
51.00
58.00
47.00
73.00
75.00
78.00
42.00
51.00
-15.00
54.00
20.00
73.00
71.00
Tax %
25.00
23.00
30.00
26.00
25.00
26.00
27.00
25.00
-22.00
27.00
23.00
29.00
25.00
Net Profit
38.00
45.00
33.00
54.00
56.00
58.00
31.00
38.00
-12.00
39.00
16.00
52.00
54.00
EPS in Rs
15.17
17.95
13.04
21.69
22.33
23.30
12.34
15.37
-4.72
15.79
6.32
20.95
21.54
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
2,276.00 1,716.00 1,296.00 1,003.00 806.00 814.00 832.00 728.00 571.00 544.00 564.00 517.00
Expenses
2,014.00 1,462.00 1,111.00 838.00 719.00 678.00 711.00 657.00 525.00 506.00 547.00 528.00
Operating Profit
262.00 254.00 184.00 165.00 86.00 135.00 121.00 71.00 46.00 37.00 16.00 -11.00
OPM %
12.00 15.00 14.00 16.00 11.00 17.00 15.00 10.00 8.00 7.00 2.90 -2.20
Other Income
23.00 -56.00 51.00 -14.00 15.00 13.00 13.00 16.00 12.00 14.00 7.00 6.00
Interest
4.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00
Depreciation
29.00 40.00 15.00 16.00 17.00 20.00 19.00 15.00 15.00 16.00 17.00 15.00
Profit before tax
252.00 156.00 220.00 134.00 83.00 127.00 114.00 73.00 44.00 36.00 6.00 -21.00
Tax %
26.00 26.00 26.00 26.00 26.00 27.00 37.00 25.00 41.00 44.00 9.00 0.00
Net Profit
188.00 116.00 162.00 99.00 62.00 93.00 72.00 54.00 26.00 20.00 5.00 -21.00
EPS in Rs
75.01 46.30 64.60 39.72 24.64 37.32 28.88 21.78 10.36 8.02 2.10 -8.34
Dividend Payout %
48.00 69.00 37.00 40.00 41.00 5.00 3.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
Reserves
868.00 765.00 707.00 584.00 506.00 451.00 359.00 296.00 242.00 218.00 151.00 146.00
Borrowings
111.00 36.00 5.00 7.00 9.00 12.00 12.00 0.00 0.00 0.00 0.00 0.00
Other Liabilities
1,006.00 712.00 362.00 389.00 337.00 306.00 330.00 261.00 214.00 193.00 247.00 261.00
Total Liabilities
1,989.00 1,518.00 1,078.00 985.00 857.00 775.00 706.00 562.00 461.00 415.00 403.00 412.00
Fixed Assets
117.00 64.00 67.00 69.00 74.00 81.00 72.00 75.00 75.00 87.00 97.00 101.00
CWIP
0.00 0.00 0.00 1.00 2.00 4.00 24.00 7.00 4.00 5.00 6.00 12.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
1,872.00 1,454.00 1,011.00 915.00 780.00 690.00 611.00 480.00 382.00 324.00 299.00 298.00
Total Assets
1,989.00 1,518.00 1,078.00 985.00 857.00 775.00 706.00 562.00 461.00 415.00 403.00 412.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
-15.00 65.00 28.00 58.00 101.00 105.00 87.00 55.00 9.00 38.00 57.00 -46.00
Cash from Investing Activity
19.00 31.00 22.00 18.00 5.00 173.00 -171.00 4.00 -9.00 0.00 -4.00 -19.00
Cash from Financing Activity
-92.00 -66.00 -44.00 -24.00 -9.00 -9.00 -6.00 0.00 0.00 0.00 -1.00 0.00
Net Cash Flow
-88.00 31.00 5.00 52.00 96.00 269.00 -90.00 59.00 -1.00 38.00 53.00 -64.00
Free Cash Flow
-18.00 64.00 18.00 53.00 94.00 99.00 74.00 37.00 3.00 33.00 48.00 -69.00
CFO/OP %
26.00 51.00 46.00 60.00 146.00 101.00 100.00 126.00 28.00 133.00 365.00 393.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
34.00 39.00 43.00 39.00 39.00 38.00 37.00 40.00 35.00 29.00 54.00 30.00
Inventory Days
272.00 208.00 140.00 193.00 164.00 198.00 197.00 186.00 229.00 121.00 141.00 157.00
Days Payable
207.00 173.00 121.00 231.00 223.00 221.00 251.00 266.00 257.00 184.00 174.00 203.00
Cash Conversion Cycle
99.00 74.00 62.00 1.00 -20.00 15.00 -17.00 -39.00 7.00 -34.00 21.00 -16.00
Working Capital Days
50.00 22.00 20.00 -18.00 -34.00 -17.00 -16.00 -14.00 -8.00 -36.00 -28.00 -15.00
ROCE %
29.00 33.00 31.00 31.00 16.00 30.00 34.00 27.00 19.00 15.00 4.00 -13.00
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
75.00
75.00
75.00
75.00
75.00
75.00
75.00
75.00
75.00
75.00
75.00
75.00
FIIs
2.68
2.78
2.71
2.74
3.03
2.89
2.92
2.90
2.79
2.73
2.66
2.69
DIIs
6.08
5.79
5.55
5.26
4.55
4.65
5.21
5.08
4.99
3.77
2.76
2.42
Public
16.24
16.42
16.73
17.00
17.41
17.45
16.85
17.02
17.21
18.50
19.57
19.89
No. of Shareholders
29,338
29,007
31,551
32,914
34,378
32,466
27,322
27,615
27,169
29,418
29,032
32,380
Corporate Actions
28 records
Back to all stocks